Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.70 |
| ▸ | NT5E | P21589 | 1/20 | 0.65 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.65 |
| ▸ | KRAS | P01116 | 3/20 | 0.64 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.61 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.61 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.61 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.60 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.60 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.60 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.60 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.60 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.60 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.60 |
| ▸ | RNASEL | Q05823 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.57 |
| ▸ | IMPDH2 | P12268 | 4/20 | 0.56 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1622486 | 0.99 | TGM2 (0.69) | TGM2NT5EFUT5KRASENPP1 | |
| SCHEMBL1622482 | 0.99 | TGM2 (0.69) | TGM2NT5EFUT5KRASENPP1 | |
| SCHEMBL234673 | 0.97 | TGM2 (0.70) | TGM2NT5EFUT5KRASENPP1 | |
| SCHEMBL21067995 | 0.97 | TGM2 (0.70) | TGM2NT5EFUT5KRASENPP1 | |
| SCHEMBL21256201 | 0.97 | TGM2 (0.70) | TGM2NT5EFUT5KRASENPP1 | |
| SCHEMBL23176397 | 0.97 | TGM2 (0.70) | TGM2NT5EFUT5KRASENPP1 | |
| SCHEMBL877839 | 0.97 | TGM2 (0.70) | TGM2NT5EFUT5KRASENPP1 | |
| SCHEMBL4011876 | 0.96 | TGM2 (0.69) | TGM2NT5EFUT5KRASENPP1 | |
| SCHEMBL6512071 | 0.96 | TGM2 (0.69) | TGM2NT5EFUT5KRASENPP1 | |
| SCHEMBL1533928 | 0.96 | TGM2 (0.69) | TGM2NT5EFUT5KRASENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117521944-A | Data statistics and processing method for investment decision of distributed photovoltaic power generation project | 国网甘肃省电力公司定西供电公司 | 2024-02-06 | — | — | CN | claimed |
| US-20230390409-A1 | FAP-ACTIVATED SERUM EXTENDED HALF-LIFE THERAPEUTIC CONJUGATES | AVACTA LIFE SCIENCES LIMITED (GB) | 2023-12-07 | — | — | US | claimed |
| CN-117042808-A | FAP activated serum half-life extending therapeutic conjugates | 阿瓦克塔生命科学有限公司 | 2023-11-10 | — | — | CN | claimed |
| EP-4237012-A1 | FAP-ACTIVATED SERUM EXTENDED HALF-LIFE THERAPEUTIC CONJUGATES | Avacta Life Sciences Limited (GB) | 2023-09-06 | — | — | EP | claimed |
| CN-115256563-B | High-strength fir glued wood beam, preparation method and bending rigidity index determination method | 中国林业科学研究院木材工业研究所 | 2023-03-21 | — | — | CN | claimed |
| CN-115486824-A | Cuff-free continuous blood pressure estimation system based on uncertainty measurement | 电子科技大学 | 2022-12-20 | — | — | CN | claimed |
| CN-115256563-A | High-strength fir glued wood beam, preparation method thereof and flexural rigidity index determination method | 中国林业科学研究院木材工业研究所 | 2022-11-01 | — | — | CN | claimed |
| CN-111476412-B | Photovoltaic power generation cost allocation research method considering carbon footprint and transaction | 国网福建省电力有限公司泉州供电公司 | 2022-07-08 | — | — | CN | claimed |
| WO-2022094262-A1 | FAP-ACTIVATED SERUM EXTENDED HALF-LIFE THERAPEUTIC CONJUGATES | AVACTA LIFE SCIENCES LIMITED (GB) | 2022-05-05 | — | — | WO | claimed |
| US-20260034244-A1 | MODIFIED FUSION PROTEIN AND USE THEREOF | PANOLOS BIOSCIENCE INC (KR) | 2026-02-05 | — | — | US | disclosed |
| US-20250369986-A1 | APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS | The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University (CN) | 2025-12-04 | — | — | US | disclosed |
| EP-4657069-A1 | APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS | The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University (CN) | 2025-12-03 | — | — | EP | disclosed |
| EP-4638148-A1 | TIRES FOR VEHICLE WHEELS | Pirelli Tyre S.p.A. (IT) | 2025-10-29 | — | — | EP | disclosed |
| US-20250269632-A1 | LOW STATIC DISCHARGE NON-BLOCKING MULTILAYER BARRIER FILM | TAGHLEEF INDUSTRIES INC. | 2025-08-28 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230390409-A1 | FAP-ACTIVATED SERUM EXTENDED HALF-LIFE THERAPEUTIC CONJUGATES | FAP, FIBP, FUCA2 | TGM2 112/4885NT5E 986/4885FUT5 950/4885 |
| US-20260034244-A1 | MODIFIED FUSION PROTEIN AND USE THEREOF | PGF, VEGFA, FLT1 | TGM2 699/4885NT5E 2959/4885FUT5 4466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.